GMP Specialist

Dorota Osińska is a Pharmacist with over the 20 years experience in pharmaceutical industry. She worked in the research department of a pharmaceutical company developing and implementing oral pharmaceutical forms. She has been a lead expert in validation and audits in Quality Assurance and Quality Assurance and Qualified Operations Manager at Polfa Warszawa S.A. (Polpharma Group) as well as the Manager of Compliance and Quality Assurance Compliance Team at Agila Specialties Polska (Mylan Group).

She participated in designing and launching new production areas and upgrading existing ones. As a quality specialist, she participated in the implementation of Good Manufacturing Practice requirements. She was an internal auditor and external auditor, auditing the manufacturers of active substances, packaging materials, medical devices, contract manufacturers and pharmacovigilance.

She oversaw the development of quality contracts, development of DGMW, complaint handling, qualitative documentation management, deviation analysis, supplier qualification, corrective and preventive actions, internal training, internal inspections and external audits.

Ms Dorota Osińska has started GMP certification process in the field of labelling, re-labelling and re-packing of investigational products.

Go back

News

Increasing Access to Breakthrough Clinical Trials for Patients in Poland

Poland is strengthening its position as one of the leading clinical research hubs in Europe

Read more …

Happy Easter from BioResearch Group

On the occasion of Easter, we would like to extend our warmest wishes of peace, joy, and renewed energy

Read more …

Clinical research reshapes nicotine regulation – new publication by BRG CEO

BioResearch Group (BRG) announces the publication of a new article by Dr Katarzyna Jarus-Dziedzic.

Read more …

BRG’s Contribution to the Advancement of an Innovative Therapy

Phase I clinical trials conducted at BRG play a key role in the development of new therapies

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2026 © Bio Research Group. All rights reserved.

 

scroll to top ▲